Table 1. Clinical and pathological characteristics of included patients from the pooled cohort.
| No recurrence (%) | Recurrence (%) | P-value | |
|---|---|---|---|
| N | 60 | 50 | |
| Follow-up | |||
| Median (IQR), d | 2366 (455) | 900 (1148) | |
| Age | |||
| Mean±s.d. (years) | 61.7±6 | 62.5±5 | 0.42a |
| Preoperative PSA | |||
| Mean±s.d. (ng ml−1) | 9.4±5.8 | 10.3±5.1 | 0.44a |
| Grade group (RP) | |||
| 1 | 4 (7) | 5 (10) | <0.001b |
| 2 | 39 (65) | 14 (28) | |
| 3 | 15 (25) | 17 (34) | |
| 4 | 2 (3) | 7 (14) | |
| 5 | 0 (0) | 7 (14) | |
| EPE | 9 (15) | 31 (62) | <0.001b |
| SVI | 4 (7) | 12 (24) | 0.014b |
| PSM | 15 (25) | 21 (42) | 0.12b |
| PCa-specific death | 0 | 3 (6) |
Abbreviations: EPE=extraprostatic extension; IQR=interquartile range; PCa=prostate cancer; PSA=prostate-specific antigen; PSM=positive surgical margins; RP=radical prostatectomy; SVI=seminal vesicle invasion.
a
Student’s t-test.
b
Exact Mantel–Haenszel linear-by-linear association χ2 test.